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Abstract
  .Vanin and co-workers Kubrina et al., Biochim. Biophys. Acta 1176 1993 240–244; Mikoyan et al., Biochim. Biophys.
 . .  .  .  .Acta 1269 1995 19–24 reported that short term 30 min iron Fe exposure potentiates nitric oxide NO production in
 .tissues of septic shock mice, based on increased formation of NO complex by diethyldithiocarbamate DETC . We have
 .reexamined the effect of Fe administration in mice treated with Escherichia coli lipopolysaccharide LPS and have not
 .  y y.found any changes in nitrosylhemoglobin HbNO or NO qNO levels in blood 30 min after Fe-citrate complex2 3
injection. However, Fe-citrate promotes NO complex formation by iron-dependent NO traps: DETC, pyrrolidinedithiocarba-
 .  .mate PDTC and N-methyl-D-glucamine dithiocarbamate MGD , when given simultaneously at 6 h after LPS. Rather than
 .potentiation of NO production, our data support that short-term iron treatment 30 min enhances in vivo spin trapping
ability of dithiocarbamate. q 1997 Elsevier Science B.V.
 .Keywords: Spin trapping; EPR; Nitric oxide; Mononitrosyl iron complex; Septic shock; Mouse
There is an unresolved debate over the interaction
of iron and infections. The availability of iron to
invading bacteria can determine the outcome of infec-
w xtion 1 . However, iron complexes of desferal and
 .diethylenetriaminepentaacetic acid DTPA protect
w xmice and primates against endotoxin shock 2 . This
 .protection was attributed to nitric oxide NO scav-
w xenging by iron complexes 3 . Sustained NO produc-
tion causes vasodilation and hypotension in septic
w xshock. Both survival 4 and hemodynamic response
w xto endotoxin 5 improved in mice with genetic dele-
 .tion of inducible nitric oxide synthase iNOS , which
is a primary source of NO generation in septic shock.
)  .Corresponding author. Tel.: q1 202 994-2301; fax: q1
 .202 994-3553; E-mail: amkoma@gwis2.circ.gwu.edu
Vanin and co-workers reported recently that short
 .term 30 min treatment with exogenous iron potenti-
ates nitric oxide production in tissues of septic shock
mice, based on increased formation of NO complex
 . w xby diethyldithiocarbamate DETC 6,7 . This is in
apparent contradiction with down regulation of NO
production in stimulated macrophages in the presence
w xof iron 8,9 . We have reexamined the effect of iron
in septic shock mice and found that short-term 30
.min iron pretreatment did not change systemic NO
level in mice. The potentiation of tissue NO complex
production after iron and dithiocarbamate administra-
tion was due to the increase in dithiocarbamate spin
trapping efficiency by exogenous iron.
 .ICR mice female 30–35 g were supplied by
 .Harlan Sprague-Dawley Indianapolis, IN . All ani-
mal experiments were guided by the principles for
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the care and use of laboratory animals as recom-
mended by the US Department of Health and Human
Services, and approved by the George Washington
University Animal Care and Use Committee.
 .Lipopolysaccharide LPS, Escherichia coli 026:B6 ,
 .pyrrolidinedithiocarbamate PDTC , deferoxamine
 .mesylate were from Sigma St. Louis, MO . Dieth-
 .yldithiocarbamate DETC was purchased from
 .Aldrich Milwaukee, WI , 3-morpholinosydnonimine
 . SIN-1 was from Cayman Chemical Co. Ann Ar-
.bor, MI . N-Methyl-D-glucamine and carbon disul-
 .fide were from Fluka Biochemika Switzerland .
Sodium N-methyl-D-glucamine dithiocarbamate was
w x 13prepared as described 10 and characterized by C-
w xNMR 11 . Other chemicals and reagents were pur-
 . ychased from Sigma St. Louis, MO . NO was mea-2
w x ysured by the Griess colorimetric assay 12 . NO was3
first converted to NOy by E. coli nitrate reductase2
w x13 and measured as described above.
 .LPS 6 mg or 60 mg per mouse was given via the
tail vein. At 6 h after LPS, the mice received 2.2
mmolrkg dithiocarbamate i.p. and 120 mmolrkg of
iron s.c., administered simultaneously with dithiocar-
bamate as Fe-citrate complex 33 mgrkg FeSO P4
7H O plus 167 mgrkg of sodium citrate, prepared2
.fresh immediately before the injection . Control ani-
 .mals received LPS plus Na-citrate 167 mgrkg . The
mice were killed 30 min after dithiocarbamate injec-
tion, then liver, kidney, lung tissues and blood were
quickly obtained. Some animals treated with iron did
not receive dithiocarbamate; blood samples obtained
from these animals were used for nitrosylhemoglobin
 . y yHbNO measurement; sera were used for NO rNO2 3
assay and liver tissue used to determine total amount
w xof free iron by iron-desferal EPR assay 14 .
EPR measurements were performed at 77 K with a
Bruker ER 200 X-band spectrometer using an EPR
 . finger Dewar Wilmad Glass, Buena, NJ . Bis di-
.thiocarbamato -Fe-NO complexes were determined
by EPR in the liver, kidney and lung tissue frozen in
liquid nitrogen.
At the time of measurement, tissue samples were
transferred to an EPR finger Dewar and the EPR
spectra recorded at 77 K. Whole blood obtained from
 .mice without anticoagulant 0.5 ml sample volume
was frozen immediately at 77 K for EPR detection of
HbNO. In order to determine total amount of bis di-
.thiocarbamato iron complex formed in tissue by
DETC and PDTC, liver tissue was homogenized 91
.mgrml in Dulbecco’s phosphate-buffered saline and
 .incubated with SIN-1 4 mM, final at 378C for 1 h.
 .Samples 46 mg tissue were frozen at 77 K and total
 .amount of bis dithiocarbamato -Fe-NO complex
formed in tissue after SIN-1 treatment was deter-
mined by EPR. Total amount of free iron was deter-
mined in the liver tissue of mice untreated with
dithiocarbamate. Liver homogenate 336 mgrml in
100 mM Hepes, 1 mM CaCl , 1 mM Mg acetate, pH2
. 7.5 was incubated with desferal final concentration
.1 mM for 10 min at the room temperature. Samples
 .151 mg tissue were frozen at 77 K and total amount
of FeIII-desferal complex formed in tissue determined
 .by EPR as described for tissue samples Fig. 1
 .Fig. 1. EPR spectra 77 K obtained from the liver tissue of septic
shock mice, which received 6 mg LPS i.v. and 6 h later were
exposed to various experimental conditions: liver tissue after s.c.
injection of iron 120 mmolrkg administered as Fe-citrate com-
.plex: 33 mgrkg FeSO P7H O and 167 mgrkg of sodium citrate4 2
 .plus i.p. injection of DETC 2.2 mmolrkg A ; liver tissue after
 .s.c. injection of sodium citrate 167 mgrkg plus i.p. injection of
 .DETC B ; liver tissue after s.c. injection of iron 120 mmolrkg
 .plus i.p. injection of MGD 2.2 mmolrkg C ; and liver tissue
 .after s.c. injection of sodium citrate 167 mgrkg plus i.p.
 .injection of MGD D . All mice were killed 30 min after
 .dithiocarbamate injection, liver tissue samples 551"4 mg were
frozen at 77 K and EPR spectra recorded as described above.
 .  .Triplet y EPR signal of DETC -Fe-NO A, B and MGD -Fe-2 2
 .NO C complex at g s2.041 shown on spectra; one of theH
 .signals of DETC -Cu complex quartet x can be seen in the2
higher field. EPR conditions were: microwave frequency 9.40
GHz, microwave power 10 mW, modulation frequency 100 KHz,
modulation amplitude 3.2 G, center field 3292 G, scan rate 60
Grmin, time constant 0.5 s.
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except: center field 1561 G, scan rate 120 Grmin,
modulation amplitude 5 G.
A number of in vivo NO assays employ iron
w xcomplexes of dithiocarbamate derivatives 6,7,15–19 .
In the presence of iron and NO, dithiocarbamates
form EPR-detectable NO complexes according to the
reaction:
XXII IIFe S CNRR qNO| Fe NO S CNRR .  .2 22 2
1 .
Where R, RX are various substitutive groups. DETC
and PDTC can chelate endogenous iron in tissue,
forming lipophilic complexes, while MGD in the
presence of iron forms water-soluble complex. Mice
were injected with iron and dithiocarbamate at 6 h
after LPS at the peak of NO production. In the
absence of exogenous iron, EPR signals of NO com-
plex were detected for DETC and PDTC, which can
chelate free iron in tissue. The water-soluble MGD -2
Fe-NO complex was detected only in the iron-treated
mice, suggesting that MGD alone did not form suffi-
cient amount of complexes with tissue Fe to allow
 .NO trapping Fig. 1 . Simultaneous administration of
Fe-citrate complex and dithiocarbamate in septic
shock mice at 6 h after LPS resulted in the prominent
augmentation of the triplet EPR signal of NO com-
 N .plex g s2.041, a s13.4 G displayed by theH H
 .liver Fig. 1 and other tissues of mice. The enhanc-
ing effect of iron was dithiocarbamate-specific; it was
 . more pronounced for PDTC Table 1 or MGD Fig.
.1 , than for DETC. In the absence of exogenous iron,
the amount of DETC -Fe-NO complex formed in the2
liver of LPS-treated ICR mice was close to that
 .reported by Kubrina et al. Fig. 2 . However, in ICR
mice Fe did not produce such a dramatic increase in
the DETC -Fe-NO complex formation, as reported in2
Fig. 2. The amount of nitrosyl-iron complex nmolrg wet wt.
.tissue formed in the liver of septic shock mice at 6 h after LPS
injection by MGD, DETC and PDTC. Mice received 6 mg LPS
 .i.v. group 1 ; 6 mg LPS and 6 h later iron – 120 mmolrkg
 .group 2 . All mice received one of dithiocarbamate derivatives
 .2.2 mmolrkg; i.p. at 6 h after LPS and were killed 30 min
later. Liver samples from groups 1 and 2 were additionally
 .incubated in vitro with SIN-1 1 h, 378C , data shown as groups 3
and 4, respectively. The amounts of NO complex in tissue were
calculated by comparing the EPR signal intensities of the tissue
sample at 77 K with the signal intensity of standard solution
containing a known concentration of the MGD -Fe-NO complex.2
) P -0.05 group 2 versus 1, group 4 versus 2; )) P -0.005
a group 3 versus 1; P -0.001 group 2 versus 1 3–5 mice per
.group .
w xmongrel mice 6 . In our experiment, PDTC -Fe-NO2
complex formation enhanced by Fe administration
was about 9-fold, comparing to control LPS-treated
 .animals Table 1 . PDTC was administered at the
time of maximum iNOS expression in the liver and
other tissues of mice. Therefore, it should not affect
the iNOS induction process. The enhancing effect of
iron did not vary in DETC-treated mice with the dose
 .of LPS Table 1 . Two-fold increase of the iron dose
administered at 6 h after LPS did not produce further
Table 1
Enhancement of dithiocarbamate NO trapping in the liver of septic shock mice after administration of Fe-citrate complex
a .  .Experimental group Dithiocarbamate-Fe-NO ratio to control Dithiocarbamate-Fe, total ratio to control
 .  .  .I LPS 6 mg qDETC & Fe 2.8"0.5 5 3.6"0.5 5
 .  .  .II LPS 60 mg qDETC & Fe 2.8"0.6 3 2.6"0.3 3
) .  .  .III LPS 6 mg qPDTC & Fe 9.0"2.0 3 2.4"0.4 3
 .Mice received LPS E. coli as a bolus i.v. injection in the tail vein 6 mg or 60 mg of LPS E. coli per animal and s.c. injection of
 .Fe-citrate complex 33 mgrkg FeSO P7H O plus 167 mgrkg sodium citrate at 6 h after LPS, control mice received LPS and sodium4 2
 .  .citrate 167 mgrkg . Dithiocarbamate was injected i.p. 2.2 mmolrkg at 6 h after LPS and animals were killed 30 min later. Symbol ‘&’
means simultaneous injection; ) P-0.01, comparing to group I.
a The results were expressed as the ratio of NO complex EPR signal intensity in tissue of Fe-citrate treated mice versus control sodium
.  .citrate-treated mice; the results presented as mean"standard error number of experiments .
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Table 2
The effect of Fe-citrate administration on NOyrNOy level in2 3
sera of septic shock mice
y yExperimental group NO qNO Free Fe2 3
 . mM nmolrg of
a.liver wet wt.
)) ) .  .A. LPSqFe-citrate 355"47 4 335"49 4
)) .  .B. LPSqcitrate 356"43 4 86"12 4
 .  .C. Normal mice 23" 7 5 110"10 4
Mice received LPS E. coli i.v. via the tail vein 6 mg per
. animal , Fe-citrate 33 mgrkg FeSO P7H O plus 167 mgrkg4 2
. sodium citrate was given as s.c. injection at 6 h after LPS group
.A and mice were killed 30 min later. Control mice received LPS
 .and sodium citrate 167 mgrkg . The data were presented as
 . )mean"standard error number of animals ; P -0.002 compar-
ing to group B; )) P -0.0005 comparing to group C.
a The amount of free iron in liver tissue was determined by EPR
in desferal-treated liver homogenate.
enhancement of DETC -Fe-NO complex formation2
 .data not shown . When the tissue samples were
incubated in vitro with SIN-1, the amount of NO
complex in the sample increased more than 3-fold
 .Fig. 2 . NO saturation of tissue DETC -Fe-NO com-2
 .plex was 26"4% ns10 . Iron administration en-
 .hanced total amount of bis dithiocarbamato iron
complex formed in liver 2.3–3.6-fold, comparing to
animals received only LPS and dithiocarbamate Ta-
.ble 1 .
Total amount of free iron in the liver was deter-
w III xmined by EPR as Fe desferal complex, which
produced a broad EPR signal at gs4.3 only a weak
EPR signal at gs4.3 was observed in the liver
.homogenate in the absence of desferal . Iron adminis-
tration significantly increased the amount of free iron
 .in the liver Table 2 . It is important to know whether
dithiocarbamates and desferal sampling the same pool
of free iron in tissue. Preincubation of liver ho-
mogenate with desferal prevented formation of
DETC -Fe complex and vice versa. The total amount2
 .of bis dithiocarbamato iron complex formed in the
liver in vivo was not significantly higher than the
amount of desferal-iron complex detected in liver
homogenate.
The increase of DETC -Fe-NO complex formation2
 .by iron at 6 h following LPS injection was observed
also in the kidney, lung and blood of septic shock
mice, implying an apparent systemic increase in the
NO production. However, the enhancing effect of
iron can also be explained by the increase of dithio-
carbamate spin trapping efficiency due to increased
iron availability, which contributes to bis dithiocar-
.bamato -Fe-NO complex formation in the new com-
partments. In order to distinguish between these alter-
natives, we determined the effect of iron administra-
tion on NOyrNOy and HbNO levels in the blood of2 3
septic shock mice. End-products of NO metabolism
HbNO and NOyrNOy are reliable indicators of2 3
w xsystemic NO production in inflammation 20–22 .
Nitrosylhemoglobin formation in the blood of septic
shock mice produced characteristic triplet EPR signal
 N .of nitrosylheme a s17.5 G centered at gs2.012.
 .Iron administration 120 mmolrkg at 6 h after LPS
 .6 mg per animal did not affect HbNO level in the
whole blood of septic shock mice killed 30 min later
 .Fig. 3 . Iron injection was also without effect after
 .lower LPS dose 60 mg per animal , which produced
 .less HbNO in the blood data not shown . Iron injec-
tion did not change the level of NOyrNOy in sera2 3
 .of LPS-treated mice Table 2 . Therefore, short-term
 .30 min iron treatment of septic shock mice did not
 . Fig. 3. EPR spectra 77 K of whole blood 0.5 ml sample
.  .volume obtained from normal mice A and mice which received
6 mg LPS i.v. and then 6 h later either s.c. injection of Fe-citrate
 .complex 33 mgrkg FeSO P7H O plus 167 mgrkg Na citrate4 2
 .  .in saline B or s.c. injection of Na citrate 167 mgrkg in saline
 .C ; mice were killed 30 min later and whole blood obtained
without anticoagulant was frozen immediately in liquid nitrogen.
EPR conditions were the same as described for Fig. 1, except:
center field 3350 G, scan rate 49 Grmin, modulation amplitude 5
G and the receiver gain was 10-fold higher. The triplet EPR
 .signal fi at g s2.012 is that of heme-NO.
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alter the systemic NO level, but enhanced in vivo
spin trapping efficiency of dithiocarbamate. The con-
clusion of this in vivo study does not contradict
previous reports on cellular iNOS down regulation by
w xiron 8,9 , since we have studied short term iron
exposure. In macrophages nuclear transcription of
cytokine-inducible NOS mRNA was decreased by
w xabout 50% in the presence of 50 mM ferric iron 8 .
w xAccording to our in vivo data 23 , iron attenuates
nitric oxide level in blood and tissue in the mouse
model of endotoxic shock, when it is given simulta-
neously with LPS.
iNOS activation is an important mechanism of
nonspecific immunity. In septic shock, however, NO
overproduction often leads to multiple organ failure
and ultimately death. iNOS-deficient mice were pro-
tected against endotoxin-induced death and hypoten-
w xsion 4,5 . It was recently speculated that inherited
attenuation of NO output via iNOS may be the reason
for higher pyrogenic thresholds reported in Afro-
American volunteers comparing to whites under the
same conditions of infection with Plasmodium falci-
w xparum 24 . However, tissue NO could be generated
w xfrom nitrite decomposition 25 , or via superoxide
anion-mediated oxidation of N G-hydroxyl-L-arginine
w xto NO 26 , thus bypassing nitric oxide synthase.
Therefore, nitric oxide scavenging may be a useful
alternative to NOS inhibition in septic shock. In
addition, all known NOS inhibitors are partially nons-
w xelective to NOS isoforms 27 . Iron chelates with
desferal and DTPA were reported to bind NO, thus
removing it in vivo and reducing animal mortality in
w xseptic shock 2,3 . The authors suggested, based on in
vitro electrochemical measurements, that iron com-
plexes could act as ‘molecular sponges’ to remove
w xexcess of NO 3 . However, they were not able to
demonstrate in vivo presence of NO complex with
iron chelator and cited previous studies, employing
dithiocarbamates to support the notion of in vivo NO
scavenging. Our data suggest that compartmentaliza-
tion of dithiocarbamate iron chelators and Fe avail-
ability to them are the essential parameters affecting
in vivo NO scavenging.
In conclusion, contrary to the previous reports
w x  .6,7 , our data support that short-term 30 min iron
pretreatment of septic shock mice does not alter the
systemic NO level, but enhances dithiocarbamate spin
trapping efficiency in vivo.
This work was supported in part by NIH grant
RO1-HL36418.
References
w x1 J.H. Brock, In: J.H. Brock, J.W. Halliday, M.J. Pippard,
 .L.W. Powell Eds. , Iron Metabolism in Health and Disease,
W.B. Saunders, London, 1994, pp. 353–389.
w x2 L. Molina, S. Studenberg, G. Wolberg, W. Kazmierski, J.
Wilson, A. Tapepalli, A.C. Chang, S. Kosanke, L. Hinshaw,
 .J. Clin. Invest. 98 1996 192–198.
w x3 W. Kazmierski, G. Wolberg, J.G. Wilson, S.R. Smith, D.S.
Williams, H.H. Thorp, L. Molina, Proc. Natl. Acad. Sci.
 .USA 93 1996 9138–9141.
w x4 X.-Q. Wei, I.G. Charles, A. Smith, J. Ure, G.-J. Feng, F.-P.
Huang, D. Xu, W. Muller, S. Moncada, F.Y. Liew, Nature
 .375 1995 408–411.
w x5 J.D. MacMicking, C. Nathan, G. Hom, N. Chartrain, D.S.
Fletcher, M. Trumbauer, K. Stevens, Q.-W. Xie, K. Sokol,
 .N. Hutchinson, H. Chen, J.S. Mudgett, Cell 81 1995
641–650.
w x6 L.N. Kubrina, V.D. Mikoyan, P.I. Mordvintcev, A.F. Vanin,
 .Biochim. Biophys. Acta 1176 1993 240–244.
w x7 V.D. Mikoyan, N.V. Voevodskaya, L.N. Kubrina, I.V.
Malenkova, A.F. Vanin, Biochim. Biophys. Acta 1269
 .1995 19–24.
w x8 G. Weiss, G. Werner-Felmayer, E.R. Werner, K. Grunewald,
 .H. Wachter, M.W. Hentze, J. Exp. Med. 180 1994 969–
976.
w x 9 E.E. Aeberhard, L.J. Ignarro, M.P. Sherman, FASEB J. 8 4,
.  .P.I 1994 2096.
w x10 L.A. Shinobu, S.G. Jones, M.M. Jones, Acta Pharmacol.
 .Toxicol. 54 1984 189–194.
w x  .11 P. Giboreau, C. Morin, J. Org. Chem. 59 1994 1205–1207.
w x12 D.L. Granger, R.R. Taintor, K.S. Boockvar, J.B. Hibss Jr.,
 .Methods Enzymol. 268 1996 142–151.
w x  .13 B. Bartholomew, Food Chem. Toxicol. 22 1984 541–543.
w x14 D.Yu. Yegorov, A.V. Kozlov, O.A. Azizova, Yu.A.
 .Vladimirov, Free Radic. Biol. Med. 15 1993 565–574.
w x15 A. Komarov, D. Mattson, M.M. Jones, P.K. Singh, C.-S.
 .Lai, Biochem. Biophys. Res. Commun. 195 1993 1191–
1198.
w x  .16 C.-S. Lai, A.M. Komarov, FEBS Lett. 345 1994 120–124.
w x17 A.M. Komarov, C.-S. Lai, Biochim. Biophys. Acta 172
 .1995 29–36.
w x18 C.-S. Lai, A.M. Komarov, In: H. Ohya-Nishiguchi, L. Packer
 .Eds. , Bioradicals Detected by ESR Spectroscopy,
Birkhauser Verlag, Basel, 1995, pp. 163–171.
w x19 T. Yoshimura, H. Yokoyama, S. Fujii, F. Takayama, K.
 .Oikawa, H. Kamada, Nature Biotechnol. 14 1996 992–994.
w x20 I.T. Mak, A.M. Komarov, T.L. Wagner, R.E. Stafford, B.F.
 .Dickens, W.B. Weglicki, Am. J. Physiol. 271 1996 C385–
C390.
w x21 A. Wennmalm, G. Benthin, A.-S. Petersson, Br. J. Pharma-
 .col. 106 1992 507–508.
( )A.M. Komaro˝ et al.rBiochimica et Biophysica Acta 1361 1997 229–234234
w x22 Y. Henry, M. Lepoivre, J.-C. Drapier, C. Ducrocq, J.-L.
 .Boucher, A. Guissani, FASEB J. 7 1993 1124–1134.
w x  .23 A.M. Komarov, I.T. Mak, W.B. Weglicki, FASEB J. 11 3
 .1997 2760.
w x24 I.A. Clark, F.M. Al-Yaman, W.B. Cowden, K.A. Rockett,
 .Lancet 348 1996 1492–1494.
w x25 J.L. Zweier, P. Wang, A. Samouilov, P. Kuppusamy, Nature
 .Med. 1 1995 804–809.
w x26 M. Modolell, K. Eichmann, G. Soler, FEBS Lett. 401
 .1997 123–126.
w x  .27 O.W. Griffith, R.G. Kilbourn, Methods Enzymol. 268 1996
375–392.
